Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sigma-1 receptor antag
>>
National Institutes of Health
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
naluzotan
(PRX-00023) / National Institutes of Health, Sawai Pharma
